The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Payments

Documenting a payment dispute without naming and shaming — the long version

MA
mi.amankwahTL2 Moderator6 Feb 2026#1

Posting this under the heading it deserves: Documenting a payment dispute without naming and shaming — the long version Everything below is what sits behind that.

I would like to talk about documentation quality as a signal, separately from product quality.

Across the certificates I have collected, the variation in what is disclosed is much larger than the variation in the purity figures. Some name the analytical procedure; some give a number and a signature.

My hypothesis is that disclosure correlates with process control, and I would like to know whether the people who audit paperwork for a living think that is naive.

7 likes 6mo
QZ
q.zhao_qaTL3Quality assurance21 Apr 2026#2

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

11 likes 3mo
IL
i.lehtinenTL2 Moderator13 Jun 2026#3

Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.

32 likes 1mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Why chargeback is not the safety net people assume
Asking directly, because I could not find a straight answer: Why chargeback is not the safety net people assume A logistics question, since the answers here are usually better than anywhere else I have…
TNEDFLILBW+22 26 2.5k 2d
Coming back to: Payment mechanics and the recovery options that do not exist
On the subject in the title: Payment mechanics and the recovery options that do not exist Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
ZSSSLKDEK+7 11 2.6k 7mo
What to keep a record of at the point of payment
What to keep a record of at the point of payment — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the…
HFBRAN 2 1.8k 16mo
Second pass at: Why chargeback is not the safety net people assume
Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually…
DBMMHB 2 25k 3mo
Payment mechanics and the recovery options that do not exist — what changed since
On the subject in the title: Payment mechanics and the recovery options that do not exist — what changed since Working notes rather than a conclusion. A logistics question, since the answers here are usually…
YRVBENBDCP+14 18 17k 13mo

Related topics — sharing the tags documentation quality, payments, research use only

TopicParticipantsRepliesViewsActivity
Batch numbers that do not match the vial label — what changed since
On the subject in the title: Batch numbers that do not match the vial label — what changed since Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
MPAMBRSVC+39 43 14k 1mo
About the Payments category
Payment mechanics, chargeback reality, and the recurring risks. No payment facilitation of any kind here. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
KHSSHKM 4 3.5k 20mo
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. Comparing FLOW ( N Engl J Med , 2024)…
NLKKNRPFI+7 11 31k 19h
Labelling requirements for research chemicals — the long version
Posting this under the heading it deserves: Labelling requirements for research chemicals — the long version Everything below is what sits behind that. I would like to talk about documentation quality as a…
LSDBHK 2 1.8k 2mo
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in…
HBELCVHNDN+35 39 688 5mo